Maura L Furey

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory
    Maura L Furey
    Mood and Anxiety Disorders Program, NIMH, NIH, Bethesda, MD 20892, USA
    J Cogn Neurosci 20:1342-53. 2008
  2. ncbi Scopolamine produces larger antidepressant and antianxiety effects in women than in men
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA
    Neuropsychopharmacology 35:2479-88. 2010
  3. ncbi Dissociation of face-selective cortical responses by attention
    Maura L Furey
    Laboratory of Brain and Cognition and Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 103:1065-70. 2006
  4. ncbi Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 63:1121-9. 2006
  5. ncbi Selective effects of cholinergic modulation on task performance during selective attention
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Neuropsychopharmacology 33:913-23. 2008
  6. ncbi Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder
    Teresa A Victor
    National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
    Arch Gen Psychiatry 67:1128-38. 2010
  7. ncbi Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial
    Wayne C Drevets
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Psychiatry 67:432-8. 2010
  8. ncbi The prominent role of stimulus processing: cholinergic function and dysfunction in cognition
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin Neurol 24:364-70. 2011
  9. ncbi Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
    Wayne C Drevets
    Section on Neuroimaging in Mood and Anxiety Disorders, National Institute of Mental Health, National Institutes of Health NIH NIMH DIRP, 15K North Dr, Room 210, Bethesda, MD 20892, USA
    Brain Struct Funct 213:93-118. 2008
  10. ncbi Neural basis of abnormal response to negative feedback in unmedicated mood disorders
    Joana V Taylor Tavares
    Department of Psychiatry, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK
    Neuroimage 42:1118-26. 2008

Detail Information

Publications13

  1. ncbi Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory
    Maura L Furey
    Mood and Anxiety Disorders Program, NIMH, NIH, Bethesda, MD 20892, USA
    J Cogn Neurosci 20:1342-53. 2008
    ....
  2. ncbi Scopolamine produces larger antidepressant and antianxiety effects in women than in men
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA
    Neuropsychopharmacology 35:2479-88. 2010
    ..6, p=0.001) showed that the antianxiety response was greater in women. Men and women show a rapid antidepressant response following scopolamine, but the magnitude of response is larger in women than in men...
  3. ncbi Dissociation of face-selective cortical responses by attention
    Maura L Furey
    Laboratory of Brain and Cognition and Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Proc Natl Acad Sci U S A 103:1065-70. 2006
    ..By contrast, the early, face-specific M170 that was not modulated by attention likely reflects a rapid, feed-forward phase of face-selective processing...
  4. ncbi Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Arch Gen Psychiatry 63:1121-9. 2006
    ..002). Subsequently a clinical trial was designed to assess more specifically the antidepressant efficacy of scopolamine...
  5. ncbi Selective effects of cholinergic modulation on task performance during selective attention
    Maura L Furey
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA
    Neuropsychopharmacology 33:913-23. 2008
    ..The findings are discussed within the context of the role of acetylcholine both in stimulus processing and stimulus salience, and in establishing attention biases through top-down and bottom-up mechanisms of attention...
  6. ncbi Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder
    Teresa A Victor
    National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA
    Arch Gen Psychiatry 67:1128-38. 2010
    ..However, few studies have investigated such biases toward implicitly presented stimuli...
  7. ncbi Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial
    Wayne C Drevets
    Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Biol Psychiatry 67:432-8. 2010
    ..The present study aimed to replicate this finding in an independent sample limited to unipolar depressives...
  8. ncbi The prominent role of stimulus processing: cholinergic function and dysfunction in cognition
    Maura L Furey
    Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin Neurol 24:364-70. 2011
    ....
  9. ncbi Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression
    Wayne C Drevets
    Section on Neuroimaging in Mood and Anxiety Disorders, National Institute of Mental Health, National Institutes of Health NIH NIMH DIRP, 15K North Dr, Room 210, Bethesda, MD 20892, USA
    Brain Struct Funct 213:93-118. 2008
    ..This paper discusses these systems together with the neurochemical systems that impinge on them and form the basis for most pharmacological therapies...
  10. ncbi Neural basis of abnormal response to negative feedback in unmedicated mood disorders
    Joana V Taylor Tavares
    Department of Psychiatry, University of Cambridge, Addenbrooke s Hospital, Cambridge, UK
    Neuroimage 42:1118-26. 2008
    ..Disrupted top-down control by the prefrontal cortex of the amygdala may underlie this abnormal response to negative feedback in unipolar depression...
  11. ncbi Pharmacological modulation of prefrontal cortical activity during a working memory task in young and older humans: a PET study with physostigmine
    Ulderico Freo
    Laboratory of Clinical Biochemistry, Medical School, University of Pisa, Via Roma, 55, I-56126 Pisa, Italy
    Am J Psychiatry 162:2061-70. 2005
    ....
  12. ncbi Beyond sensory images: Object-based representation in the human ventral pathway
    Pietro Pietrini
    Laboratory of Clinical Biochemistry, Department of Experimental Pathology, University of Pisa Medical School, I 56126 Pisa, Italy
    Proc Natl Acad Sci U S A 101:5658-63. 2004
    ..These results demonstrate that the representation of objects in the ventral visual pathway is not simply a representation of visual images but, rather, is a representation of more abstract features of object form...